PET-Technology

Regional Network of PET Centers

Establishment of a network of regional PET centers for diagnostic procedures

In its initial stage, portfolio company PET-Technology will open positron-emission tomography centers in Bryansk, Lipetsk, Orel, Tambov, and Ufa. To provide the PET centers with the radiopharmaceuticals, the project company will establish production of isotope ₁₈O and organize two cyclotron sites—in Lipetsk and Ufa—for production of short-lived isotopes.

PET is used for the diagnosis of cancers, including diagnosis in early stages, and for diagnosis and treatment in cardiology and neurology. Radiopharmaceuticals are selectively absorbed by tumor tissues and tissues whose metabolic activity is high. By combining into one instrument the functions of PET and computer tomography, benefits of both ensue—a three-dimensional picture of functional changes in tissue overlays a high-resolution image of the patient’s organs. PET diagnostics identify 18 percent more tumors in early stages, significantly improving prognoses and decreasing mortality.

By producing isotope ₁₈O—which is done using low-temperature rectification in the presence of isotope exchange reactions on nanoclusters—the project will be able to meet demand from the Russian PET centers and enter the international market for diagnostic agents.

Area of application

• Medicine

Market

• Diagnostic services: patients
• Isotope ₁₈O: domestic and foreign PET centers

Competitive advantages

• Proprietary production of essential isotope ₁₈O
• Proprietary production of isotopes and radiopharmaceuticals for domestic use and export